Concord Wealth Partners Bristol Myers Squibb CO Transaction History

Concord Wealth Partners

$559 Million
Q2 2024

A detailed history of Concord Wealth Partners transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Concord Wealth Partners holds 5,498 shares of BMY stock, worth $279,958. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,498

Previous 6,799 19.14%

Holding current value

$279,958

Previous $368,000 38.04%

% of portfolio

0.04%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$40.25 - $52.99 $52,365 - $68,939	-1,301 Reduced 19.14%	5,498 $228,000
Q1 2024 Apr 30, 2024	SELL	$47.98 - $54.4 $1.14 Million - $1.3 Million	-23,840 Reduced 77.81%	6,799 $368,000
Q4 2023 Apr 30, 2024	BUY	$48.48 - $57.85 $437,289 - $521,807	9,020 Added 41.72%	30,639 $1.57 Million
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $437,289 - $521,807	9,020 Added 41.72%	30,639 $1.57 Million
Q3 2023 Apr 30, 2024	SELL	$57.89 - $64.73 $522,167 - $583,864	-9,020 Reduced 29.44%	21,619 $1.25 Million
Q3 2023 Oct 25, 2023	BUY	$57.89 - $64.73 $76,993 - $86,090	1,330 Added 6.56%	21,619 $1.25 Million
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $458,520 - $509,115	7,197 Added 54.97%	20,289 $1.3 Million
Q1 2023 Apr 26, 2023	BUY	$65.71 - $74.53 $256,926 - $291,412	3,910 Added 42.58%	13,092 $907,000
Q4 2022 Jan 27, 2023	SELL	$68.48 - $81.09 $262,620 - $310,980	-3,835 Reduced 29.46%	9,182 $660,000
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $43 - $25,741	-335 Reduced 2.51%	13,017 $925,000
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $86,708 - $95,496	1,194 Added 9.82%	13,352 $1.03 Million
Q1 2022 Apr 20, 2022	BUY	$61.48 - $73.72 $38,978 - $46,738	634 Added 5.5%	12,158 $888,000
Q4 2021 Jan 21, 2022	BUY	$53.63 - $62.52 $380,933 - $444,079	7,103 Added 160.67%	11,524 $718,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $276,323 - $323,677	-4,670 Reduced 51.37%	4,421 $262,000
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $24,206 - $26,361	391 Added 4.49%	9,091 $607,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $261,214 - $293,789	4,402 Added 102.42%	8,700 $549,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $248,166 - $281,218	4,298 New	4,298 $267,000

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.

Account

Concord Wealth Partners Bristol Myers Squibb CO Transaction History